AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be ...

The increasingly fast-paced lifestyle has depleted the ordinary person’s usual diet of essential nutrients that increases the risk of atherosclerosis, despite the age group and the growth rate of ...

The AstraZeneca PLC ADR AZN slipped 0.55% to $65.37 Tuesday, on what proved to be an all-around mixed trading session for the ...

NDAQ:AZN) AstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information ...

Daiichi Sankyo buys solid tumour ADC from Glycotope for $132.5m Daiichi Sankyo has finalised the acquisition of intellectual ...

AstraZeneca PLC (AZN) stock saw a decline, ending the day at $65.73 which represents a decrease of $-1.28 or -1.91% from the prior close of $67.01. The stock opened at $65.88 and touched a low of $65.

We recently published a list of Billionaire George Soros Stock Portfolio: Top 10 Stock Picks. In this article, we are going ...

This latest approval for Orpathys in NSCLC makes the drug available in both the first- and second-line settings.

Shares of AstraZeneca PLC AZN slipped 1.77% to £106.30 Tuesday, on what proved to be an all-around poor trading session for ...

The payment scheme for people injured by vaccines has cost taxpayers more to run than it has paid out to victims, official ...

LOS ANGELES, CA / ACCESSWIRE / January 14, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...

A lack of trust in the government and scientists contributed to “false narratives” about the mass vaccination programme ...